063160.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 08:08):

Stats
Dzisiejszy wolumen	12 748.00
Średni wolumen	19 187.00
Kapitalizacja rynkowa	134.95B
EPS	KRW0 ( 2024-04-25 )
Następna data zysków	( KRW0 ) 2024-07-26
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	-5.83
ATR14	KRW18.81 (0.08%)

Wolumen Korelacja

Długi: 0.11 (neutral)

Krótki: -0.20 (neutral)

Signal:(49.914) Neutral

CKD Bio Corp. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CKD Bio Corp. Korelacja - Waluta/Towar

0.74
( moderate )

0.66
( moderate )

-0.07
( neutral )

0.59
( weak )

0.19
( neutral )

-0.76
( moderate negative )

CKD Bio Corp. Finanse

Annual	2023
Przychody:	KRW160.35B
Zysk brutto:	KRW5.01B (3.12 %)
EPS:	KRW-4 409.90

FY	2023
Przychody:	KRW160.35B
Zysk brutto:	KRW5.01B (3.12 %)
EPS:	KRW-4 409.90

FY	2022
Przychody:	KRW156.04B
Zysk brutto:	KRW16.79B (10.76 %)
EPS:	KRW-3 044.61

FY	2021
Przychody:	KRW142.24B
Zysk brutto:	KRW13.31B (9.35 %)
EPS:	KRW-1 215.54

Financial Reports:

No articles found.

CKD Bio Corp.

CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.